Figure 1. Clinical outcomes of AML patients based on the most immature leukemic cell phenotype.
(A) Overall survival and (B) event-free survival by the most immature phenotype detectable in leukemia cells. (Adapted from Gerber et al, 2016 [6])
(A) Overall survival and (B) event-free survival by the most immature phenotype detectable in leukemia cells. (Adapted from Gerber et al, 2016 [6])